Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines

Bleeding Clinical Trial

— APP  

Official title:

Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02884999
• Other study ID #: APP
• Status: Completed
• Phase: N/A
• First received: August 19, 2016
• Last updated: August 26, 2016
• Start date: May 2015
• Est. completion date: November 2015

Study information

• Verified date: August 2016
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: The Commission nationale de l’informatique et des libertés
• Study type: Observational

Clinical Trial Summary

This cohort study describes the epidemiology of trauma patients and their management in a French academic trauma center. It also aims to determine what recommendations from the European trauma guidelines is applied in routine.

Description:

Severe trauma is responsible for more than 5 millions of deaths annually worldwide. Haemorrhagic shock secondary to uncontrolled bleeding is the leading cause of preventable death in this population, making bleeding and coagulopathy treatment a key element of the early phase of trauma management. European trauma guidelines have been developed to help clinicians in severe trauma management and improve bleeding and coagulopathy treatment in this population. Investigating who these guidelines are followed in routine is crucial to identify opportunities to improve early management of bleeding severe trauma patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 145
• Est. completion date: November 2015
• Est. primary completion date: November 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Trauma patients with injury severity score equal to or higher than 16 year old admitted to the Brest academic trauma centre within the 24 hours following the trauma

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Bleeding
• Blood Coagulation Disorders
• Hemorrhage
• Hemostatic Disorders
• Wounds and Injuries
• Wounds and Injury

Locations

Country	Name	City	State
France	CHRU de BRest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients treated as per studied guidelines		first 24 hours of trauma management	No